Effects of chronic antidepressant treatments on 5-HT and NA transporters in rat brain: An autoradiographic study

Neurochemistry International

Volumn 38, Issue 1, 2001, Pages 63-74

  Hébert, Caroline ^a   Habimana, Angelina ^a   Élie, Robert ^a,b   Reader, Tomás A ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b CENTRE DE RECHERCHE FERNAND SEGUIN   (Canada)

Author keywords

Citalopram; Desipramine; Fluoxetine; Nisoxetine; Trimipramine; Venlafaxine

Indexed keywords

ANTIDEPRESSANT AGENT; CITALOPRAM; DESIPRAMINE; FLUOXETINE; NISOXETINE; NORADRENALIN; SEROTONIN; TRIMIPRAMINE; TRITIUM; VENLAFAXINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BRAIN; BRAIN REGION; CONTROLLED STUDY; DENTATE GYRUS; DORSAL RAPHE NUCLEUS; DRUG BINDING; HIPPOCAMPUS; LOCUS CERULEUS; MALE; NONHUMAN; PRIORITY JOURNAL; RAPHE NUCLEUS; RAT;

ANIMALS; ANTIDEPRESSIVE AGENTS; AUTORADIOGRAPHY; BRAIN CHEMISTRY; CARRIER PROTEINS; CITALOPRAM; CYCLOHEXANOLS; DESIPRAMINE; FLUOXETINE; GENE EXPRESSION REGULATION; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; NERVE TISSUE PROTEINS; NOREPINEPHRINE PLASMA MEMBRANE TRANSPORT PROTEINS; ORGAN SPECIFICITY; RADIOLIGAND ASSAY; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; STEREOTAXIC TECHNIQUES; SYMPORTERS; TRIMIPRAMINE;

EID: 0343932733     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-0186(00)00043-7     Document Type: Article

References (51)

1. Agren H., Mefford I.N., Rudorfer M.V., Linnoila M., Potter W.Z. Interacting neurotransmitter systems: a non-experimental approach to the 5-HIAA-HVA correlation in humans. J. Psychiatr. Res. 20:1986;175-193.
2. Agren H., Koulu M., Saavedra J.M., Potter W.Z., Linnoila M. Circadian covariation of norepinephrine and serotonin in the locus coeruleus and dorsal raphe nucleus in the rat. Brain Res. 397:1987;353-358.
3. 3H]citalopram as markers of the human brain 5-HT uptake site: a comparison study. J. Neural Transm. 97:1994;27-40.
4. 1A receptors. J. Neural Transm. 106:1999;75-105.
5. Audet M.A., Descarries L., Doucet G. Quantified regional and laminar distribution of the serotonin innervation in the anterior half of adult rat cerebral cortex. J. Chem. Neuroanat. 2:1989;29-44.
6. 3H]nisoxetine autoradiography. Brain Res. 582:1992;208-214.
7. Benmansour S., Cecchi M., Morilak D.A., Gerhardt G.A., Javors M.A., Gould G.G., Frazer A. Effects of chronic antidepressant treatments on serotonin transporter function, density, and mRNA level. J. Neurosci. 19:1999;10494-10501.
8. Berger M., Gastpar M. Trimipramine: a challenge to current concepts on antidepressives. Eur. Arch. Psychiatry Clin. Neurosci. 246:1996;235-239.
9. Canadian Council on Animal Care, 1993. Guide to the Care and Use of Experimental Animals, Volume 1, 2nd edition. Olfert, E.D., Cross, B.M., McWilliam, A.A. (Eds.) Bradda Printing Services Inc., Ottawa.
10. Carli M., Reader T.A. Regulation of central serotonin transporters by chronic lithium: an autoradiographic study. Synapse. 27:1997;83-89.
11. 3H]nisoxetine binding sites in the cat brain: an autoradiographic study. Neuroscience. 69:1995;259-270.
12. Charney D.S., Menkes D.B., Heninger G.R. Receptor sensitivity and the mechanism of action of antidepressant treatment: implications for the etiology and therapy of depression. Arch. Gen. Psychiatry. 38:1981;1160-1180.
13. 3H]5-HT uptake: effect of administration of various antidepressant treatments. Neuropharmacology. 32:1993;737-743.
14. 3H]imipramine. J. Pharmacol. Exp. Ther. 242:1987;364-371.
15. Descarries L., Soucy J.P., Lafaille F., Mrini A., Tanguay R. Evaluation of three transporter ligands as quantitative markers of serotonin density in rat brain. Synapse. 21:1995;131-139.
16. 3H]Paroxetine binding and serotonin content of rat brain: absence of changes following antidepressant treatments. Eur. J. Pharmacol. 23:1993;137-142.
17. 3H]citalopram binding in rat and human brain: species differences and relationships to serotonin innervation patterns. Brain Res. 591:1992;181-197.
18. 3H]paroxetine binding to the 5-hydroxytryptamine uptake site in an animal model of depression. J. Neurochem. 56:1991;1581-1586.
19. Frazer A. Pharmacology of antidepressants. J. Clin. Psychopharm. 17:(I):1997;2S-18S.
20. Fuxe K., Ogren S.O., Agnati L.F., Benfenati F., Fredholm B., Andersson K., Zini I., Eneroth P. Chronic antidepressant treatment and central 5-HT synapses. Neuropharmacology. 38:1983;389-400.
21. 3H]nisoxetine binding in rat brain. J. Neurochem. 64:1995;2792-2800.
22. 4 receptors in rats. Naunyn Schmiedeberg's Arch. Pharmacol. 356:1997;22-28.
23. Golden R.N., Rudorfer M.V., Sherer M.A., Linnoila M., Potter W.Z. Bupropion in depression. Part I: Biochemical effects and clinical response. Arch Gen. Psychiatry. 45:1988;139-143.
24. Golden R.N., DeVane C.L., Laizure S.C., Rudorfer M.V., Sherer M.A., Potter W.Z. Bupropion in depression. Part II: the role of metabolites in clinical outcome. Arch Gen. Psychiatry. 45:1988;145-149.
25. Heninger G.R., Delgado P.L., Charney D.S. The revised monoamine theory of depression: a modulatory role for monoamines, based on new findings from monoamine depletion experiments in humans. Pharmacopsychiatry. 29:1996;2-11.
26. 2 receptors in rat brain: an autoradiographic study. Synapse. 14:1993;324-331.
27. Hyttel J. Citalopram: basic and clinical studies. Progr. Neuropharmacol. Biol. Psychiatry. 6:1982;275-336.
28. Jones R.S.G., Olpe H.R. An increase in sensitivity of rat cingulate cortical neurones to substance P occurs following withdrawal of chronic administration of antidepressant drugs. Br. J. Pharmacol. 81:1984;659-664.
29. Klimek V., Stockmeier C., Overholser J., Meltzer H.Y., Kalka S., Dilley G., Ordway G.A. Reduced levels of norepinephrine transporters in the locus coeruleus in major depression. J. Neurosci. 17:1997;8451-8458.
30. Kovachic G.A., Aronson C.E., Brunswick D.J. Effects of repeated administration of antidepressants on serotonin uptake sites in limbic and neocortical structures of rat brain determined by quantitative autoradiography. Neuropsychopharmacology. 7:1992;317-324.
31. Kramer M.S., Cutler N., Feighner J., Shrivastava R., Carman J., Sramek J.J., Reines S.A., Liu G., Snavely D., Wyatt-Knowles E., Hale J.J., Mills S.G., MacCoss M., Swain C.J., Harrison T., Hill R.G., Hefti F., Scolnick E.M., Cascieri M.A., Chicchi G.G., Sadowski S., Williams A.R., Hewson L., Smith D., Carlson E.J., Hargreaves R.G., Rupniak N.M. Distinct mechanism for antidepressant activity by blockade of central substance P receptors. Science. 281:1998;1640-1645.
32. 3H]citalopram. J. Chem. Neuroanat. 15:1998;155-171.
33. Martensson B., Nyberg S., Toresson G., Brodin E., Bertilsson L. Fluoxetine treatment of depression. Clinical effects, drug concentrations and monoamine metabolites and N-terminally extended substance P in cerebrospinal fluid. Acta Psychiatr. Scand. 79:1989;586-596.
34. McRae-Deguerce A., Bérod A., Keller A., Chouvet G., Joh T.H., Pujol J.-F. Alterations in tyrosine hydroxylase activity elicited by raphe nuclei lesions in the rat locus coeruleus: evidence for the involvement of serotonin afferents. Brain Res. 235:1982;285-381.
35. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates. 1997;Academic Press, San Diego.
36. 3H]citalopram to the 5-HT transporter from brain and platelets. Eur. J. Pharmacol. 206:1991;243-250.
37. Potter W.Z. Adrenoceptors and serotonin receptor function: relevance to antidepressant mechanisms of action. J. Clin. Psychiatry. 57:(4):1996;4-8.
38. Pujol J.-F., Keane P., McRae A., Lewis B.D., Renauld B. Biochemical evidence for serotoninergic control of the locus coeruleus. Garattini S., Pujol J.-F. Interactions between Putative Neurotransmitter in the Brain. 1978;401-410 Raven Press, New York.
39. Reader T.A., Jasper H.H. Interactions beween monoamines and other transmitters in cerebral cortex. Descarries L., Reader T.A., Jasper H.H. Monoamine Innervation of Cerebral Cortex. 1984;195-225 Allan R. Liss, New York.
40. Reader T.A., Strazielle C. Quantitative autoradiography of monoamine uptake sites and receptors in rat and mouse brain. Boulton A.A., Baker G.B., Bateson A.N. Cell Neurobiology Techniques, Neuromethods. vol. 33:1999;1-51 Humana Press, Totowa, NJ.
41. Richelson E. Biological basis of depression and therapeutic relevance. J. Clin. Psychiatry. 52:(6):1991;4-10.
42. Richelson E. Synaptic effects of antidepressants. J. Clin. Psychopharm. 16:(2):1996;1S-7S.
43. Schildkraut J.J. The catecholamine hypothesis of affective disorders: a review of supporting evidence. Am. J. Psychiatry. 122:1965;509-522.
44. 3H]citalopram quantitative autoradiography. J. Chem. Neuroanat. 10:1996;157-171.
45. 2- and β-adrenergic receptors in pcd mutant mice: a quantitative autoradiographic study. Neuroscience. 94:1999;287-304.
46. 3H]Nisoxetine: a radioligand for quantitation of norepinephrine uptake sites by autoradiography or by homogenate binding. J. Pharmacol. Exp. Ther. 260:1992;427-436.
47. 3H]nisoxetine: a new radioligand for norepinephrine uptake sites in brain. Eur. J. Pharmacol. 191:1990;239-243.
48. 3H]Ultrafilm: application to multiple benzodiazepine receptors. Neurosci. Methods. 6:1982;59-73.
49. Wong D.T., Threlkeld P.G., Best K.L., Bymaster F.P. A new inhibitor of norepinephrine uptake devoid of affinity for receptors in rat brain. J. Pharmacol. Exp. Ther. 222:1982;61-65.
50. Zhu M.Y., Ordway G.A. Down-regulation of norepinephrine transporters on PC12 cells by transporter inhibitors. J. Neurochem. 68:1997;134-141.
51. Zilles K. The Cortex of the Rat. A Stereotaxic Atlas. 1985;Springer-Verlag, Berlin.